Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-02 08:15 am Purchase | 2024-09-30 | 13D | Seres Therapeutics, Inc. MCRB | NESTLE SA | 21,781,753 14.290% | 21,781,753 (New Position) | Filing History |
| 2024-04-05 12:21 pm Sale | 2024-03-31 | 13G | Seres Therapeutics, Inc. MCRB | BlackRock Inc. BLK | 6,825,399 4.500% | -514,055 (-7.00%) | Filing History |
| 2024-02-12 12:23 pm Sale | 2023-12-31 | 13G | Seres Therapeutics, Inc. MCRB | JANUS HENDERSON GROUP PLC JHG | 483 0.000% | -11,247,809 (-100.00%) | Filing History |
| 2024-02-09 09:49 am Purchase | 2024-02-08 | 13G | Seres Therapeutics, Inc. MCRB | FMR LLC | 19,388,579 14.999% | 699,818 (+3.74%) | Filing History |
| 2024-01-29 5:25 pm Purchase | 2023-12-31 | 13G | Seres Therapeutics, Inc. MCRB | BlackRock Inc. BLK | 7,339,454 5.700% | 1,090,368 (+17.45%) | Filing History |
| 2023-11-07 12:57 pm Sale | 2023-10-31 | 13G | Seres Therapeutics, Inc. MCRB | FEDERATED HERMES INC. FHI | 5,175,805 4.040% | -6,324,715 (-55.00%) | Filing History |
| 2023-05-10 10:16 am Sale | 2023-04-30 | 13G | Seres Therapeutics, Inc. MCRB | FEDERATED HERMES INC. FHI | 11,500,520 9.000% | -6,585,418 (-36.41%) | Filing History |
| 2023-04-06 09:29 am Sale | 2023-03-31 | 13G | Seres Therapeutics, Inc. MCRB | BlackRock Inc. BLK | 6,249,086 5.000% | -209,888 (-3.25%) | Filing History |
| 2023-02-10 11:46 am Purchase | 2022-12-31 | 13G | Seres Therapeutics, Inc. MCRB | JANUS HENDERSON GROUP PLC JHG | 11,248,292 9.000% | 6,193,193 (+122.51%) | Filing History |
| 2023-02-09 12:31 pm Purchase | 2023-02-09 | 13G | Seres Therapeutics, Inc. MCRB | FMR LLC | 18,688,761 14.999% | 4,911,691 (+35.65%) | Filing History |
| 2023-02-09 11:32 am Purchase | 2022-12-30 | 13G | Seres Therapeutics, Inc. MCRB | The Vanguard Group | 6,092,937 4.890% | 1,416,672 (+30.29%) | Filing History |
| 2023-02-03 3:19 pm Sale | 2022-12-31 | 13G | Seres Therapeutics, Inc. MCRB | STATE STREET CORP STT | 4,564,139 3.660% | -221,450 (-4.63%) | Filing History |
| 2023-02-03 12:10 pm Purchase | 2022-12-31 | 13G | Seres Therapeutics, Inc. MCRB | BlackRock Inc. BLK | 6,458,974 5.200% | 584,616 (+9.95%) | Filing History |
| 2023-02-01 12:15 pm Purchase | 2022-12-31 | 13G | Seres Therapeutics, Inc. MCRB | FEDERATED HERMES INC. FHI | 18,085,938 14.520% | 103,682 (+0.58%) | Filing History |
| 2022-08-09 4:02 pm Purchase | 2022-07-31 | 13G | Seres Therapeutics, Inc. MCRB | BlackRock Inc. BLK | 5,874,358 4.700% | 11,667 (+0.20%) | Filing History |
| 2022-07-22 1:34 pm Sale | 2022-07-18 | 13D | Seres Therapeutics, Inc. MCRB | Nestle Health Science US Holdings Inc. | 7,594,038 6.100% | -298,852 (-3.79%) | Filing History |
| 2022-07-11 2:13 pm Purchase | 2022-06-30 | 13G | Seres Therapeutics, Inc. MCRB | FEDERATED HERMES INC. FHI | 17,982,256 14.500% | 11,068,120 (+160.08%) | Filing History |
| 2022-07-07 5:00 pm Purchase | 2022-07-05 | 13D | Seres Therapeutics, Inc. MCRB | Flagship VentureLabs IV LLC | 23,493,063 18.900% | 8,443,072 (+56.10%) | Filing History |
| 2022-02-14 4:11 pm Sale | 2021-12-31 | 13G | Seres Therapeutics, Inc. MCRB | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -4,702,206 (Position Closed) | Filing History |
| 2022-02-14 1:46 pm Purchase | 2021-12-31 | 13G | Seres Therapeutics, Inc. MCRB | FEDERATED HERMES INC. FHI | 6,914,136 7.530% | 6,914,136 (New Position) | Filing History |